RealNews

Bird flu vaccine that cost Spain EUR 120m may be useless

Spain has spent EUR 120 million stockpiling doses of a drug to fight bird flu infections in humans that scientists are now warning could soon be ineffective. According to a report published on Wednesday in the journal Nature, mutations of the H5N1 bird flu virus are making it resistant to Tamiflu, the principal drug that Spain and most other countries started stockpiling in 2005 at the height of the bird flu pandemic. Full Story

OODA Analyst

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.